论文部分内容阅读
随着对慢性阻塞性肺病(COPD)的深入研究,肺功能检查可基本上反映出该病的病变程度.但有时对不同病因引起的本病仍难以得到完善的解释.而酶学检查在COPD患者的应用研究仍鲜见报道.本文对COPD患者的酶学改变和肺功能改变进行相关性探讨,旨在为COPD患者提供一些有实际意义和客观的指标.1 材料与方法确诊的150例COPD患者分为急性期组和缓解期组.急性期组共80例,男55例(68%),女25例(32%),平均年龄55.2岁;缓解期组共70例、男47例(65%),女23例(35%),平均年龄53.3岁.LDH、CPK测定:LDH和CPK肌酸磷酸激酶
With the further study of chronic obstructive pulmonary disease (COPD), pulmonary function tests can basically reflect the degree of the disease, but sometimes for different etiology caused by the disease is still difficult to get a perfect explanation.Enzyme assays in COPD The application of the patient is still rarely reported.In this paper, COPD patients with enzymatic changes and changes in lung function were discussed in order to provide some practical and objective indicators for COPD patients.Materials and Methods150 cases of COPD Patients were divided into acute group and remission group.Acute phase group of 80 cases, 55 males (68%), 25 females (32%), mean age 55.2 years; remission group a total of 70 cases, 47 males ( 65%), 23 females (35%), average age 53.3 years old.LDH, CPK determination: LDH and CPK creatine phosphokinase